Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 558,731 | 620,134 | -29,399 | -98,110 | -63,796 |
| Depreciation Amortization | -1,828 | -361 | 3,205 | 3,075 | 1,795 |
| Income taxes - deferred | 110,333 | 110,333 | -110,333 | N/A | 0 |
| Accounts receivable | 3,262 | 2,003 | -2,760 | 1,000 | 165 |
| Other Working Capital | -11,150 | -5,480 | -10,119 | -12,841 | -13,293 |
| Other Operating Activity | 23,190 | 11,021 | 17,194 | 8,350 | 7,626 |
| Operating Cash Flow | $682,538 | $737,650 | $-132,212 | $-98,526 | $-67,503 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -909,731 | N/A | N/A | N/A | N/A |
| PPE Investments | -1,934 | -1,095 | -692 | -568 | -528 |
| Purchase Of Investment | N/A | -249,525 | -364,539 | -25,579 | -25,477 |
| Sale Of Investment | 259,784 | 76,088 | 110,564 | 85,033 | 46,900 |
| Other Investing Activity | 997 | 0 | 3,394 | 3,406 | 3,407 |
| Investing Cash Flow | $-650,884 | $-174,532 | $-251,273 | $62,292 | $24,302 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,570 | -760 | -4,000 | -3,032 | -1,976 |
| Common Stock Issued | 8,086 | 3,364 | 389,031 | 388,479 | 387,009 |
| Financing Cash Flow | $6,516 | $2,604 | $385,031 | $385,447 | $385,033 |
| Exchange Rate Effect | -11 | -18 | 654 | 613 | 548 |
| Beginning Cash Position | 161,900 | 161,900 | 159,700 | 159,700 | 159,700 |
| End Cash Position | 200,059 | 727,604 | 161,900 | 509,526 | 502,080 |
| Net Cash Flow | $38,159 | $565,704 | $2,200 | $349,826 | $342,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | 682,538 | 737,650 | -132,212 | -98,526 | -67,503 |
| Capital Expenditure | -1,934 | -1,095 | -692 | -568 | -528 |
| Free Cash Flow | 680,604 | 736,555 | -132,904 | -99,094 | -68,031 |